H1N1 Flu Virus under an electron microscope The Food and Drug Administration on Tuesday approved vaccines designed to protect against the H1N1 influenza virus, a key step before starting a vaccination campaign. The approval was announced by Health and Human Services Secretary Kathleen Sebelius at a hearing that was held by the House Energy and Commerce Committee. An FDA spokeswoman said the agency approved vaccines made by a unit of Sanofi-Aventis SA, Novartis AG, CSL Ltd. and AstraZeneca PLC's MedImmune unit. MedImmune makes a vaccine in the form of mist delivered through the nose rather than a shot. Ms. Sebelius said a large-scale vaccination program will begin in mid-October. The U.S. has spent more than $1 billion to purchase and administer a total of 195 million H1N1 vaccine doses being made by five companies, including GlaxoSmithKline PLC. Ms. Sebelius said that the agency's officials are still working on that application. About 40 million to 50 million vac...
Blowing your mind away!